Sebastien Beauzile grew up calling his sickle cell disease “the thing over all my life.” From childhood into his early twenties, it was always there — episodes of searing chest pain, back pain that came without warning, skin ulcers, the constant awareness that his own blood cells were shaped wrong and that there was nothing he could do about it. He had been a patient at Cohen Children’s Medical Center on Long Island for more than two decades, cycling through management and setbacks the way so many sickle cell patients do.
Then, in late 2023, his medical team at Cohen offered him something different. A new genetic therapy called Lyfgenia, which used his own modified bone marrow to correct the disease from within. Sebastien became the first person in New York State to receive the treatment. Months later, surrounded by his doctors and his mother — who said she couldn’t remember the last time she hadn’t heard her son complain about pain — Sebastien sat grinning while the room sang Happy Birthday to him.
“It’s my new birthday,” he said. “Now nothing’s going to stop me.”
The Hospitals Behind the Miracles
Stories like Sebastien’s are not anomalies in New York’s pediatric hospital system. They are its defining characteristic — the product of decades of accumulated expertise, relentless research, and a concentration of specialized talent that exists almost nowhere else on earth.
Cohen Children’s Medical Center, part of Northwell Health, is nationally ranked in 10 pediatric specialties by U.S. News & World Report for 2025–2026, and holds the top spot in New York State for children’s hospital care for the 18th consecutive year. It is New York’s largest Level 1 pediatric trauma center. It was also the first hospital in the state to administer Zynteglo, a separate gene therapy that treated an eight-year-old boy’s beta-thalassemia — another inherited blood disorder — and later became the first to administer Casgevy, a third genetic therapy for sickle cell disease, in December 2025.
Three firsts in rapid succession. This is not coincidence. This is what institutional commitment to the frontier of medicine looks like in practice.
Manhattan’s Children’s Hospital
One hundred and thirty-eight years ago, a small brownstone on Lexington Avenue opened its doors as Babies Hospital — the first facility in New York City dedicated solely to the care of children. Care at that time was focused on the first three years of life, because childhood mortality in that era was at its most devastating in infancy.
Today, that institution has become NewYork-Presbyterian Morgan Stanley Children’s Hospital, located on the Upper West Side and affiliated with Columbia University. It is still Manhattan’s only hospital dedicated solely to children. It is also a place where pediatric history has been made repeatedly: researchers here performed the first successful pediatric heart transplant, helped identify cystic fibrosis as a disease, and created the Apgar score — the newborn assessment tool used in delivery rooms around the world to this day.
For 2025–2026, NewYork-Presbyterian Children’s Hospital ties for the number one children’s hospital in New York State, with national rankings across 10 pediatric specialties. Among its patients is Yasin, a boy born with Tetralogy of Fallot — a rare heart condition in which oxygen-poor blood flows to the rest of the body instead of the lungs. His doctors implanted one of the first-ever heart valves designed to grow alongside him. Yasin, who had two open-heart surgeries as an infant, is now playing basketball and pursuing his passion for drawing.
Hassenfeld and the Cardiology Crown
On the east side of Manhattan, Hassenfeld Children’s Hospital at NYU Langone holds a distinction that matters enormously to families facing one of the most frightening diagnoses imaginable: it is ranked the number one pediatric cardiology and heart surgery program in New York State. Nationally recognized in five pediatric specialties, it combines NYU Langone’s broader reputation for surgical excellence with a facility designed specifically around the needs of young patients and their families.
For parents who receive a cardiac diagnosis for a child — often before birth, during a routine prenatal ultrasound — the journey to a specialist can feel like falling. Having a nationally ranked program in the same city is not a small thing. It is, in many cases, everything.
What Rankings Can’t Capture
Numbers tell part of the story. Cohen Children’s ten national rankings. NewYork-Presbyterian’s century of pediatric firsts. Mount Sinai Kravis Children’s Hospital’s nationally ranked programs in endocrinology, gastroenterology, and nephrology. The U.S. News designations that guide families toward these institutions when stakes are highest.
But what the rankings cannot capture is Sebastien’s mother, who said she hadn’t heard her son mention pain since he came home. They cannot capture what it means to a parent to watch a child who had two open-heart surgeries before the age of two lace up his sneakers and head to a basketball court. They cannot capture the eight-year-old Long Island boy whose beta-thalassemia was treated with a gene therapy that didn’t exist in the form it does today just a few years ago — and who can now grow up in a body that works.
New York’s pediatric hospitals are, above all, places where children go when the stakes are highest — and leave when the unimaginable becomes possible.